EE200100578A - Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat - Google Patents

Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat

Info

Publication number
EE200100578A
EE200100578A EEP200100578A EEP200100578A EE200100578A EE 200100578 A EE200100578 A EE 200100578A EE P200100578 A EEP200100578 A EE P200100578A EE P200100578 A EEP200100578 A EE P200100578A EE 200100578 A EE200100578 A EE 200100578A
Authority
EE
Estonia
Prior art keywords
inhibitor
carboxypeptidase
pharmaceutical preparation
preparation containing
thrombin
Prior art date
Application number
EEP200100578A
Other languages
English (en)
Estonian (et)
Inventor
Abrahamsson Tommy
Nerme Viveca
Polla Magnus
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9901572A external-priority patent/SE9901572D0/xx
Priority claimed from SE9901573A external-priority patent/SE9901573D0/xx
Priority claimed from SE9902902A external-priority patent/SE9902902D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200100578A publication Critical patent/EE200100578A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100578A 1999-05-03 2000-05-03 Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat EE200100578A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9901572A SE9901572D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9901573A SE9901573D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9902902A SE9902902D0 (sv) 1999-08-13 1999-08-13 New formulation
PCT/SE2000/000847 WO2000066152A1 (en) 1999-05-03 2000-05-03 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor

Publications (1)

Publication Number Publication Date
EE200100578A true EE200100578A (et) 2003-02-17

Family

ID=27355973

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100578A EE200100578A (et) 1999-05-03 2000-05-03 Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat

Country Status (26)

Country Link
US (1) US6974800B1 (xx)
EP (1) EP1181048B1 (xx)
JP (1) JP2002543148A (xx)
KR (1) KR100725206B1 (xx)
CN (1) CN100518820C (xx)
AR (1) AR023819A1 (xx)
AT (1) ATE447964T1 (xx)
AU (1) AU763772B2 (xx)
BR (1) BR0010255A (xx)
CA (1) CA2371217A1 (xx)
CZ (1) CZ20013932A3 (xx)
DE (1) DE60043297D1 (xx)
EE (1) EE200100578A (xx)
ES (1) ES2335383T3 (xx)
HK (1) HK1042442B (xx)
HU (1) HUP0201615A3 (xx)
IL (1) IL145951A0 (xx)
IS (1) IS6140A (xx)
MX (1) MXPA01011044A (xx)
MY (1) MY126962A (xx)
NO (1) NO20015308L (xx)
NZ (1) NZ515063A (xx)
SK (1) SK15652001A3 (xx)
TR (1) TR200103151T2 (xx)
TW (1) TWI232106B (xx)
WO (1) WO2000066152A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
KR100681632B1 (ko) 1999-09-14 2007-02-09 메이지 세이카 가이샤 리미티드 카르복시펩티다아제 ｂ 저해활성을 갖는 포스폰산 유도체
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
SE0103272D0 (sv) 2001-09-28 2001-09-28 Astrazeneca Ab Chemical compounds
JP2005516972A (ja) 2002-01-22 2005-06-09 ファイザー・インク 血栓疾患の治療のためのｔａｆｉ−ａ阻害剤として使用される３−（イミダゾリル）−２−アミノプロピオン酸
US6713496B2 (en) 2002-01-22 2004-03-30 Pfizer Inc 3-(imidazolyl)-2-alkoxypropanoic acids
CA2714873A1 (en) 2002-03-21 2003-10-02 Schering Aktiengesellschaft Plasma carboxypeptidase b inhibitors
CA2612597C (en) * 2005-06-24 2015-03-31 Drugrecure Aps Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract
MX2015016961A (es) 2013-06-10 2016-04-25 Sanofi Sa Derivados de urea macrociclicos como inhibidores de tafia, su preparacion y su uso como productos farmaceuticos.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1393338A (fr) 1964-01-08 1965-03-26 Rech S Pharma Et Scient Nouveau dérivé de la cystéine et sa préparation
US3766206A (en) 1971-11-03 1973-10-16 Pfizer 18beta-glycyrrheting acid amides useful as antiulcer agents
FR2266502A1 (en) 1974-04-08 1975-10-31 Synpharm Sa N-(2-thenoyl)-cysteine and esters - with mucolytic activity, prepd. from cysteine (esters) and thenoyl chloride
US4113715A (en) 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4177277A (en) * 1977-01-17 1979-12-04 E. R. Squibb & Sons, Inc. Method for alleviating hypertension
JPS545949A (en) 1977-06-16 1979-01-17 Hisamitsu Pharmaceut Co Inc Novel cyclohexanecarboxylic acid and its derivatives
FR2430945A2 (fr) 1978-07-12 1980-02-08 Chauvin Blache Lab Nouveaux derives de la cysteine, leur procede de fabrication et leur application en therapeutique
US4708965A (en) 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
DE3838467C2 (de) 1988-11-12 1998-12-10 Agfa Gevaert Ag Fotografisches Aufzeichnungsmaterial
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
IT1249650B (it) 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
KR0173034B1 (ko) 1995-04-28 1999-03-30 성재갑 선택적 트롬빈 억제제
GB9525620D0 (en) * 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
US5859271A (en) * 1996-04-15 1999-01-12 Virginia Commonwealth University Cytoprotective compounds
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
US5993815A (en) * 1996-11-08 1999-11-30 University Of Vermont Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI)
AU6959898A (en) * 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies

Also Published As

Publication number Publication date
NO20015308D0 (no) 2001-10-30
CN1350463A (zh) 2002-05-22
IS6140A (is) 2001-11-01
EP1181048A1 (en) 2002-02-27
AU763772B2 (en) 2003-07-31
NZ515063A (en) 2003-08-29
AR023819A1 (es) 2002-09-04
BR0010255A (pt) 2002-02-13
ATE447964T1 (de) 2009-11-15
KR100725206B1 (ko) 2007-06-07
HUP0201615A3 (en) 2006-07-28
HUP0201615A2 (en) 2002-09-28
NO20015308L (no) 2001-12-03
CA2371217A1 (en) 2000-11-02
MXPA01011044A (es) 2002-06-04
EP1181048B1 (en) 2009-11-11
CN100518820C (zh) 2009-07-29
HK1042442B (zh) 2010-04-09
PL356119A1 (en) 2004-06-14
TR200103151T2 (tr) 2002-04-22
MY126962A (en) 2006-11-30
AU4447200A (en) 2000-11-17
IL145951A0 (en) 2002-07-25
SK15652001A3 (sk) 2002-07-02
WO2000066152A1 (en) 2000-11-09
KR20020003386A (ko) 2002-01-12
ES2335383T3 (es) 2010-03-26
TWI232106B (en) 2005-05-11
HK1042442A1 (en) 2002-08-16
US6974800B1 (en) 2005-12-13
JP2002543148A (ja) 2002-12-17
CZ20013932A3 (cs) 2002-04-17
DE60043297D1 (de) 2009-12-24

Similar Documents

Publication Publication Date Title
EE04904B1 (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
IS5794A (is) Lyfjasamsetning sem inniheldur COX-2-hemil og iNOS-hemil
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
DE69807420D1 (de) Pharmazeutische aerosolzusammensetzung
EE200200149A (et) Kinasoliinühendid ja neid sisaldavad ravimkoostised
EE200000652A (et) Farmatseutiline kompositsioon ja produkt
EE200200097A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
DE69904312T2 (de) Pharmazeutische aerosolformulierung
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
PT102291A (pt) Metanossulfonato de paroxetina processos para a sua preparacao composicao farmaceutica contendo o mesmo e sua utilizacao
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE60003445D1 (de) Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend
EE200100543A (et) Madala molekulmassiga trombiini inhibiitorit ja selle eelravimit sisaldav ravivorm
EE200100578A (et) Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat
EE9900545A (et) Farmatseutiline kompositsioon
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
EE200200073A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
ATE295150T1 (de) Pharmazeutische zusammensetzungen
BR9710568A (pt) Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2
SE9904819L (sv) En ny farmaceutisk komposition
SE9804128D0 (sv) A new pharmaceutical composition
BR1101151A (pt) Compostos e composição farmacêutica